Long-term Cardiovascular Safety of Salmeterol Powder Pharmacotherapy in Adolescent and Adult Patients With Chronic Persistent Asthma

This publication has 24 references indexed in Scilit:

• Comparison of Diskus^TMInhaler, a New Multidose Powder Inhaler, with Diskhaler^TMInhaler for the Delivery of Salmeterol to Asthmatic Patients
  Journal of Asthma, 1995
• The pharmacology of salmeterol
  Life Sciences, 1993
• Twelve month comparison of salmeterol and salbutamol as dry powder formulations in asthmatic patients. European Study Group.
  Thorax, 1993
• Risks Versus Benefits of Inhaled ??2-Agonists in the Management of Asthma
  Drug Safety, 1992
• Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma
  The Lancet, 1990
• The biochemical effects of high-dose inhaled salbutamol in patients with asthma
  European Journal of Clinical Pharmacology, 1989
• Cardiovascular and hypokalaemic effects of inhaled salbutamol, fenoterol, and isoprenaline.
  Thorax, 1989
• β-Adrenergic Receptors in Congestive Heart Failure: Present Knowledge and Future Directions
  Cardiology, 1989
• Salmeterol, a new long acting inhaled beta 2 adrenoceptor agonist: comparison with salbutamol in adult asthmatic patients.
  Thorax, 1988
• CARDIAC ARRHYTHMIAS CAUSED BY NEBULISED BETA-AGONIST THERAPY
  The Lancet, 1987